 (Gut 1995; 36: 459-461) 
Autoimmune chronic active hepatitis (AICAH) is a disorder in which immune reactions against antigens are believed to be the pathogenic mechanism.' It is now evident that recognition of self is essential to the normal functioning of the immune system2 and that AICAH points to a regulatory disorder within the immune system.3 The treatment of AICAH is immunosuppression and its goal is remission of disease as evidenced by a decline in the aminotransferase activities to less than twice the upper limit of the normal range as well as a reduction in the histological evidence of hepatic inflammation.
Corticosteroids alone or in combination with azathioprine have been shown to improve liver function tests and enhance survival in most patients.4-6 About 70% of patients achieve remission.7-9 Cyclosporin has been used in the treatment of a number of autoimmune diseases.'0-13 Its use in AICAH is limited to two cases in published works.'4 15 We During the ensuing two months the patient's aminotransferase activities decreased AST=221 U/1 and ALT= 188 U/1) but he became profoundly cushingoid and developed a gastric ulcer, which was treated successfully with ranitidine 300 mg twice daily. An attempt was then made to reduce the patient's corticosteroid dose (October 1991), but his liver disease relapsed with a significant rise in his transminsase activities (AST= 1400 U/1 and ALT= 1098 U/1) that required a hospital admission. Azathioprine at a dose of 1 mg/kg was introduced in combination with the prednisone but resulted in an attack of pancreatitis and had to be stopped.
Over the next six months the patient was maintained with prednisone 30 
Discussion
The treatment of AICAH is immunosuppression and the drugs used to achieve remission in most cases are corticosteroids alone or in combination with azathioprine. Side effects of the corticosteroids are dose dependent and include changes such as cushingoid appearance, weight gain, acne, osteoporosis, myopathy, cataract formation, irritability, and psychosis. [16] [17] [18] Severe corticosteroid side effects such as gastric ulceration, diabetes, and compression fractures occur in 16% of patients with AICAH.19 Azathioprine is an analogue of 6 mercaptopurine and it is this last metabolite that is responsible for most of the side effects.20
Mercaptopurine interferes with the synthesis of adenine and guanine nucleotides but its exact mechanism of action in AICAH is unknown.20
The drug increases the efficacy of the corticosteroids per dose given, thus permitting the patient to be treated with lower doses of corticosteroids. The major side effects are leucopenia and thrombocytopenia. Nausea, vomiting, anorexia, and diarrhoea tend to only occur with high doses. Alopecia, rashes, fever, arthralgias, retinopathy, Raynaud's disease, pulmonary oedema, and pancreatitis have been described.8 20 21 The reported use of cyclosporin A in AICAH unresponsive to corticosteroids and azathioprine is limited to two case reports. '4 15 One was a 51 year old man who developed a hypersensitivity reaction to the azathioprine, the other was a 14 year old boy whose parents refused the use of azathioprine. Both cases were resistant to the use of high dose corticosteroids. Both had dramatic responses to the cyclosporin with minimal side effects.
Cyclosporin was that of stripes of interstitial fibrosis with tubular atrophy. A less common finding was that of arteriolar changes -a finding thought to be reversible on withdrawal of the drug. Other side effects associated with cyclosporin use include hypertension, hyperkalaemia, hyperuricaemia, anaemia, tremor, hypertrichosis, gingival hyperplasia, paraesthesiae, and gastrointestinal intolerance.30 Our patient has to date shown none of these side effects. In summary we present a case of AICAH refractory to high dose corticosteroids and azathioprine responding dramatically to cyclosporin. It seems to have a role in the treatment of corticosteroid resistant AICAH and thus merits further investigation.
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